Download Docs
Export

APOLMYA

50213124 | Trademark citeCite Docket

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Nov. 11, 2026
Serial No. 50213124
Examining Attorney null
Class Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated diseases; 005; 006; 018; 044; 046; 051; 052
APOLMYA
Case Type Trademark
Status New application awaiting assignment to an examining attorney. <a href="https://www.uspto.gov/dashboard/trademarks/application-timeline.html">See current trademark processing wait times </a> for more information.
Last Updated: 8 hours ago
Filing Date # Docket Text
to view the full docket.